🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Germany / NCT05762250
Recruiting Not applicable

Auricular Acupuncture in Patients With Advanced Cancer: a Randomized Clinical Trial.

NCT05762250 · tracked via the Priya Life Science Germany tracker
Phase
Not applicable
Started
2023-08-13
Last updated
2025-07-31

Condition(s) studied

FatiguePainDepressionAdvanced Tumour Diseases

Investigational drug(s) / intervention(s)

Auricular Acupuncture

Auricular Acupuncture: Within the NADA protocol, 5 defined points on the patient's ears are treated according to a standardized concept (shen men, kidney, lung, liver, vegetative I).

Study summary

In the present study, the effect of ear acupressure treatment according to the NADA protocol on the quality of life of patients with advanced tumour diseases. (all stages) will be investigated. Furthermore, the effect of ear acupressure on anxiety and depression, pain, fatigue and sleep of the patients will be assessed.

Eligibility

Sex
ALL
Min age
18 Years
Max age
70 Years
Healthy volunteers
No
Inclusion Criteria: * Adult patients with advanced tumour diseases on current therapy, who suffer from persistent disease- or therapy-associated symptoms and limitations (screening by distress thermometer, score ≥ 5) * Informed consent. Exclusion Criteria: * medical reasons or * a mental condition which, in the opinion of the investigator, does not allow the patient to participate in the study, * a planned radiation therapy in the area of the skull (to avoid potential scattered radiation), * a missing legally binding signature on the informed consent form, * participation in another acupuncture/acupressure study.

Primary outcome measure(s)

Trial sites (2)

FacilityCityRegionStatus
Robert Bosch Krankenhaus Stuttgart Germany Recruiting
University Hospital Wuerzburg Würzburg Germany Recruiting

More University Hospital Tuebingen trials in Germany

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05762250 on ClinicalTrials.gov ↗ ← All trials in Germany